Effects of tobacco smoking on the kinetics of the pupillary light reflex: A comparison between smokers and non-smokers

Neuropsychobiology

Volumn 52, Issue 4, 2005, Pages 169-175

  Morte, A ^a   Benito, L ^a   Grasa, E ^a   Clos, S ^a   Riba, J ^a   Barbanoj, M J ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Light reflex; Pupil; Tobacco smoking

Indexed keywords

ADULT; ARTICLE; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; KINETICS; LIGHT INTENSITY; LUMINANCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PUPIL REFLEX; REGRESSION ANALYSIS; SMOKING CESSATION;

ADULT; CROSS-OVER STUDIES; FEMALE; HUMANS; KINETICS; LIGHT; MALE; PREVALENCE; REFLEX, PUPILLARY; SMOKING; TOBACCO USE DISORDER;

EID: 27944465244     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088859     Document Type: Article

References (31)

1. Lowenstein O, Loewenfeld IE: The pupil; in Davson H (ed): The Eye. Muscular Mechanisms. New York, Academic Press, 1962. vol 3, pp 231-267.
2. Smith SA: Pupillary function in autonomic failure: in Bannister R (ed): Autonomic Failure, ed 2. Oxford, Oxford University Press, 1988, pp 393-412.
3. Heller P, Perry F, Jewett D, Levine JD: Autonomic components of the pupillary light reflex. Invest Ophthalmol Vis Sci 1990;31:156-162.
4. Morley MJ, Bradshaw CM, Szabadi E: Effects of clonidine and yohimbine on the pupillary light reflex and carbacol evoked sweating in healthy volunteers. Br J Clin Pharmacol 1991;31:99-101.
5. Leung NKC, Bradshaw CM, Szabadi E: Effect of high ambient temperature on the kinetics of the pupillary light reflex in healhy volunteers. Br J Clin Pharmacol 1992;33:458-460.
6. Domino EF: Nicotine, a unique psychoactive drug; in Adlkofer F, Thurau K (eds): Advances in Pharmacological Sciences. Boston, Birkhäuser, 1991, pp 501-507.
7. Kadoya C, Matsuoka S, Domino EF: Effects of tobacco smoking on the Hoffman reflex. Neuropsychopharmacology 1993;9:233-238.
8. Kadoya C, Domino EF, Matsuoka S: Relationship of electroencephalographic and cardiovascular changes to plasma nicotine levels in tobacco smokers. Clin Pharmacol Ther 1994;55:370-377.
9. Roberts JD, Adams AJ: The short-term effects of smoking on ocular accommodation and pupil size. J Am Optom Assoc 1969;40:77528-77530.
10. Henningfield JE, Miyasato K, Johnson RE, Jasinsky DR: Rapid physiologic effects of nicotine in humans and selective blockade of behavioral effects by mecamylamine. NIDA Res Monogr 1983;43:259-265.
11. Furuta M, Miyao M: Acute effects of tobacco smoking on the autonomic nervous system in comparison with alcohol drinking. Jap J Alcohol Stud 1992;27:647-656.
12. Domino EF, Ni LS, Zhang H: Effects of tobacco smoking on human ocular smooth pursuit. Clin Pharmacol Ther 1996;61:349-359.
13. Lie TC, Domino EF: Effects of tobacco smoking on the human pupil. Int J Clin Pharmacol Ther 1999;37:184-188.
14. Costa PT, McRae RR: NEO PI-R inventario de personalidad NEO revisado. Madrid, TEA Ediciones, 1992.
15. Katz B, Mueller K, Helmle H: Binocular eye movement recording with CCD arrays. Neuroophthalmology 1987;7:81-91.
16. Dütsch M, Hilz MJ, Rauhut U, Solomon J, Neundörfer B, Axelrod FB: Sympathetic and parasympathetic pupillary dysfunction in familial dysautonomia. J Neurol Sci 2002;195:77-83.
17. Wilhelm H, Wilhelm B: Clinical applications of pupillography. J Neuroophthalmol 2003;23:42-49.
18. Smith SA, Smith SE: Reduced pupillary light reflexes in diabetic autonomic neuropathy. Diabetologia 1983;24:330-332.
19. Ishikawa S, Oono S, Hikita H: Drugs affecting the iris muscle; in Dikstein S (ed): Drugs and Ocular Tissues. Basel, Karger, 1977, pp 288-382.
20. Kobinger W: Central alpha-adrenergic system as target for hypotensive drugs. Rev Physiol Biochem Pharmacol 1978;81:39-100.
21. Bakes A, Bradshaw CM, Szabadi E: Attenuation of the pupillary light reflex in anxious patients. Br J Clin Pharmacol 1990;30:377-381.
22. Shiffman SM, Jarvik ME: Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 1976;50:35-39.
23. Hatsukami DK, Hughes JR, Pickens RW, Svikis D: Tobacco withdrawal symptoms: an experimental analysis. Psychopharmacology 1984;84:231-236.
24. Benowitz NL, Henningfield JE: Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med 1994;331:123-125.
25. Lowenstein O, Loewenfeld IE: Influence of retinal adaptation upon the pupillary reflex to light in normal man. Am J Ophthalmol 1961;51:644-654.
26. Davis M: The role of the amygdala in conditioned fear; in Aggleton J (ed): The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. New York, Wiley-Liss. 1992. pp 255-305.
27. Davis M, Falls MA, Campeau S, Kim M: Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 1993;58:175-198.
28. Charney DS, Bremner JD, Redmon DE: Noradrenergic neural substrates for anxiety and fear; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995, pp 387-396.
29. Benowitz NL: Clinical pharmacology of nicotine. Annu Rev Med 1986;37:21-32.
30. Dujic Z, Roerig DL, Schedewie HK, Kampine JP, Bosnjak ZJ: Presynaptic modulation of ganglionic ACh release by muscarinic and nicotinic antagonists. Am J Physiol 1990;259:R288-R293.
31. Taylor P: Agents acting at the neuromuscular junction and autonomic ganglia; in Hardman JG, Limbird LE (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed 9. New York, Mc Graw-Hill, 1996, pp 177-197.